Intrinsiqq
Geron Corporation logo

Geron Corporation Quality Score

GERN

⊜ Compare
Quality10

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-9.8x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-6.0x

Negative FCF, no valuation support

Revenue Growth
0/100
-2.2%

Below 2%, essentially flat

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
147.1%

Heavy dilution above 5%

Margin Trend
0/100
-51432.5pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-$179M

Net cash position, no leverage concern

2020
$196M
$30.0M
2021
$184M
$55.0M
2022
$173M
$56.0M
2023
$334M
$86.0M
TTM
$301M
$122M
CashDebt
Return on Capital
0/100
-11.6%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Geron (GERN) quality: score, margins and returns

Geron (GERN) scores 10/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100 and -11.6% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Geron (GERN) a high-quality business?+

Geron scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -11.6% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Geron's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from GERN's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Geron scores well and where it falls behind.

What is Geron's return on invested capital (ROIC)?+

Geron earns about -11.6% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to GERN's margins and growth on this scorecard to judge durability.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 6 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GERN

CompareIntrinsic value
INVAInnoviva Inc.
$21.26+1.58%56
CNTACentessa Pharmaceuticals plc
No recent price10
IDYAIdeaya Biosciences Inc.
$32.36+3.29%40
SYRESpyre Therapeutics, Inc.
$99.24-0.03%10
PCRXPacira BioSciences Inc.
$36.40+0.03%58
HRMYHarmony Biosciences Holdings, Inc.
$34.42-7.04%82
LPCNLipocine Inc.
$1.44-1.37%40
VRTXVertex Pharmaceuticals Incorporated
$549.04+3.44%47

Held by ETFs

GERN is in 26 US ETFs. The largest of them, with GERN's weight in each:

Spot a number that looks wrong? Check it in GERN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GERN

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.